Celltrion
068270.KS
#687
Rank
HK$290.14 B
Marketcap
HK$1,326
Share price
-1.02%
Change (1 day)
45.60%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): HK$14.75

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$14.82. In 2024 the company made an earnings per share (EPS) of HK$10.50 a decrease over its 2023 EPS that were of HK$20.82.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$14.7540.47%
2024HK$10.50-49.57%
2023HK$20.82-2.08%
2022HK$21.26-11.72%
2021HK$24.082.03%
2020HK$23.6082.8%
2019HK$12.9118.31%
2018HK$10.91-36.33%
2017HK$17.14161.25%
2016HK$6.562.86%
2015HK$6.3817.84%
2014HK$5.415.87%
2013HK$5.11-70.85%
2012HK$17.54134.09%
2011HK$7.4943.59%
2010HK$5.2274.49%
2009HK$2.99317.8%
2008HK$0.72-71.7%
2007HK$2.53